Aspira Pathlab & Diagnostics Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002885, "name": "Aspira Pathlab", "stock_name": "Aspira Pathlab", "full_name": "Aspira Pathlab & Diagnostics Ltd", "name_url": "stocks-analysis/aspira-pathlab", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "131.25", "chg": 2.55, "chgp": "1.98%", "dir": 1, "prev_price": "128.70", "mcapval": "132.00 Cr", "mcap": "Micro Cap", "scripcode": 540788, "symbol": "", "ind_name": "Healthcare Services", "ind_code": 94, "sector_id": 35, "indexname": "India SENSEX", "isin": "INE500C01017", "curr_date": "Jun 25, 03:30 PM", "curr_time": "09:52 AM", "last_traded_at": "Jun 25, 03:30 PM IST", "bse_nse_vol": 1504, "exc_status": "Active", "traded_date": "Jun 25, 2026", "traded_date_str": "2026 06 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aspira-pathlab-1002885-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4074939", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AspiraPathlabDi_mojoScore_4074939.png", "date": "2026-06-27 10:10:34", "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 June 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4055834", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AspiraPathlabDi_mojoScore_4055834.png", "date": "2026-06-16 10:11:10", "description": "Aspira Pathlab & Diagnostics Ltd is rated Sell by MarketsMOJO. This rating was last updated on 18 May 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 June 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trend, and technical outlook." }, { "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4026249", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AspiraPathlabDi_mojoScore_4026249.png", "date": "2026-06-01 10:10:04", "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 01 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Aspira Pathlab Gains 17.59%: 8 Key Factors Driving the Surge", "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-gains-1759-8-key-factors-driving-the-surge-4022803", "imagepath": "", "date": "2026-05-30 12:10:35", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> New 52-week high (Rs.118.90)</p>\n <p><strong>26 May:</strong> New 52-week high and all-time high (Rs.124.50 / Rs.122.95)</p>\n <p><strong>27 May:</strong> New 52-week and all-time highs (Rs.130 / Rs.128.99)</p>\n <p><strong>29 May:</strong> New 52-week and all-time highs (Rs.133 / Rs.132.96)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.113.35</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.133.29</div><div c..." }, { "title": "Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 133", "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-new-52-week-high-at-rs133-4020488", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_priceRelatedfactors_4020488.png", "date": "2026-05-29 12:37:07", "description": "Surging past its previous peaks, Aspira Pathlab & Diagnostics Ltd reached a fresh 52-week high of Rs 133 on 29 Jun 2026, marking a remarkable rally of over 156% in the past year. This milestone comes amid a sustained 13-day winning streak, underscoring the stock's robust price momentum despite a broader market that has struggled to maintain gains." }, { "title": "Aspira Pathlab & Diagnostics Ltd Hits All-Time High of Rs 132.96 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-all-time-high-amid-strong-market-performance-4020466", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_priceRelatedfactors_4020466.png", "date": "2026-05-29 12:08:07", "description": "Extending a remarkable rally that has spanned several months, Aspira Pathlab & Diagnostics Ltd surged to a fresh all-time high of Rs 132.96 on 29 May 2026, marking a significant milestone for the healthcare services micro-cap. This price level caps a stunning 156.7% gain over the past year, vastly outpacing the Sensex, which has declined 7.1% over the same period." }, { "title": "Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 130", "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-new-52-week-high-of-rs130-4016538", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_priceRelatedfactors_4016538.png", "date": "2026-05-27 10:04:33", "description": "Surging past its previous peaks, Aspira Pathlab & Diagnostics Ltd touched a fresh 52-week high of Rs 130 on 27 May 2026, marking a remarkable rally of over 135% from its low of Rs 49 in the past year. This milestone comes amid a sustained technical uptrend that has propelled the stock well above all key moving averages, signalling robust momentum in the healthcare services sector." }, { "title": "Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 130", "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-new-52-week-high-at-rs130-4016542", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_priceRelatedfactors_4016542.png", "date": "2026-05-27 10:04:33", "description": "Surging to an all-time high of Rs 130 on 27 May 2026, Aspira Pathlab & Diagnostics Ltd has demonstrated remarkable price momentum, doubling from its 52-week low of Rs 49 within the past year. This rally stands out amid a broadly subdued market backdrop, underscoring the stock’s technical resilience and sustained buying interest." }, { "title": "Aspira Pathlab & Diagnostics Ltd Hits All-Time High of Rs 128.99 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-all-time-high-at-rs12899-4016142", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_priceRelatedfactors_4016142.png", "date": "2026-05-27 09:38:06", "description": "Extending a remarkable winning streak to 12 sessions, Aspira Pathlab & Diagnostics Ltd surged to a fresh all-time high of Rs 128.99 on 27 May 2026, marking a 102.21% gain over this period. This rally has significantly outpaced the Sensex, which declined 0.22% on the same day, underscoring the stock’s strong relative performance within the healthcare services sector." } ], "total": 6171, "sid": "1002885", "stock_news_url": "https://www.marketsmojo.com/news/aspira-pathlab-diagnostics-1002885" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "24-Jun-2026", "details": "Intimation of closure of Trading window for quarter ended 30.06.2026", "source": "BSE" }, { "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011", "datetime": "11-Jun-2026", "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Deepali Arvind Bhanushali & PACs", "source": "BSE" }, { "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011", "datetime": "11-Jun-2026", "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Raj Arvind Bhanushali & PACs", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: New 52-week high (Rs.118.90)

26 May: New 52-week high and all-time high (Rs.124.50 / Rs.122.95)

27 May: New 52-week and all-time highs (Rs.130 / Rs.128.99)

29 May: New 52-week and all-time highs (Rs.133 / Rs.132.96)

Read full news article

Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 133

2026-05-29 12:37:07

Surging past its previous peaks, Aspira Pathlab & Diagnostics Ltd reached a fresh 52-week high of Rs 133 on 29 Jun 2026, marking a remarkable rally of over 156% in the past year. This milestone comes amid a sustained 13-day winning streak, underscoring the stock's robust price momentum despite a broader market that has struggled to maintain gains.

Read full news article

Aspira Pathlab & Diagnostics Ltd Hits All-Time High of Rs 132.96 as Momentum Builds Across Timeframes

2026-05-29 12:08:07

Extending a remarkable rally that has spanned several months, Aspira Pathlab & Diagnostics Ltd surged to a fresh all-time high of Rs 132.96 on 29 May 2026, marking a significant milestone for the healthcare services micro-cap. This price level caps a stunning 156.7% gain over the past year, vastly outpacing the Sensex, which has declined 7.1% over the same period.

Read full news article

Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 130

2026-05-27 10:04:33

Surging past its previous peaks, Aspira Pathlab & Diagnostics Ltd touched a fresh 52-week high of Rs 130 on 27 May 2026, marking a remarkable rally of over 135% from its low of Rs 49 in the past year. This milestone comes amid a sustained technical uptrend that has propelled the stock well above all key moving averages, signalling robust momentum in the healthcare services sector.

Read full news article

Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 130

2026-05-27 10:04:33

Surging to an all-time high of Rs 130 on 27 May 2026, Aspira Pathlab & Diagnostics Ltd has demonstrated remarkable price momentum, doubling from its 52-week low of Rs 49 within the past year. This rally stands out amid a broadly subdued market backdrop, underscoring the stock’s technical resilience and sustained buying interest.

Read full news article

Aspira Pathlab & Diagnostics Ltd Hits All-Time High of Rs 128.99 as Momentum Builds Across Timeframes

2026-05-27 09:38:06

Extending a remarkable winning streak to 12 sessions, Aspira Pathlab & Diagnostics Ltd surged to a fresh all-time high of Rs 128.99 on 27 May 2026, marking a 102.21% gain over this period. This rally has significantly outpaced the Sensex, which declined 0.22% on the same day, underscoring the stock’s strong relative performance within the healthcare services sector.

Read full news article